Kyowa Kirin Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kyowa Kirin Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kyowa Kirin Co Ltd Strategy Report
- Understand Kyowa Kirin Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Kyowa Kirin Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3513809B9 | Grant | MEDIZINISCHE ZUSAMMENSETZUNG MIT TIVOZANIB | A61K31/4439; A61K31/4709; A61K31/517; A61K45/00; A61K47/02; A61K47/10; A61K47/14; A61K47/26; A61K47/32; A61K47/34; A61K47/38; A61K47/40; A61K47/6951; A61K9/0048; A61K9/08; A61K9/14; A61K9/5138; A61K9/5161; A61P27/02; A61P9/10 | September 21, 2022 |
| WO2022191182A1 | Application | COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT | September 15, 2022 | |
| WO2022191183A1 | Application | COMPOSITION AND IMPROVING AGENT HAVING INFLAMMATION-SUPPRESSING ACTION | September 15, 2022 | |
| EP4056232A1 | Application | DCR3-VARIANTE | A61K38/00; A61K38/16; A61P29/00; A61P37/00; A61P37/02; A61P37/06; A61P37/08; C07K14/70578; C07K14/715; C07K14/7151; C07K16/00; C07K19/00; C07K2319/00; C07K2319/30; C12N15/62; C12N15/63; C12N15/85; C12N2800/107; C12N5/10; C12P21/02 | September 14, 2022 |
| AU2021220471A1 | Application | Bispecific antibody that binds to CD3 | A61K39/395; A61P35/00; C07K16/00; C07K16/18; C07K16/28; C07K16/46; C12N15/63; C12N15/74; C12N15/80; C12N15/81; C12N5/10; G01N33/574 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer